| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.091 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.099 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.027 | 0.6 |